The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

6 articles for Q Xia


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of novel 2-hydroxyl-4-benzyloxybenzyl aniline derivatives as potential multifunctional agents for the treatment of Parkinson's disease.EBI
North Sichuan Medical College
Design, synthesis, and biological evaluation of indazole derivatives as selective and potent FGFR4 inhibitors for the treatment of FGF19-driven hepatocellular cancer.EBI
Wenzhou Medical University
Biological evaluation and SAR analysis of novel covalent inhibitors against fructose-1,6-bisphosphatase.EBI
Anhui University of Technology
Design and synthesis of alkyl substituted pyridino[2,3-D]pyrimidine compounds as PI3Kα/mTOR dual inhibitors with improved pharmacokinetic properties and potent in vivo antitumor activity.EBI
Nanjing University of Chinese Medicine
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitorsBDB
Merck Sharp & Dohme
PYRAZOLE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOFBDB
Sichuan Kelun-Biotech Biopharmaceutical